ClinicalTrials.gg
Not yet recruitingNCT07802067STARUpdated Oct 5, 2026

Skills Training and Relief for Orofacial Pain

An interventional study of Empowered Relief in Chronic Orofacial Pain and Orofacial Pain, sponsored by University of Kentucky. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by University of Kentucky · Not applicable, Interventional, and Treatment

Updated Oct 5, 2026Eligibility revisedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Chronic orofacial pain conditions (COFP) are associated with substantial physical and psychological burden and are best treated with multidisciplinary approaches combining psychological interventions and comprehensive orofacial pain care. Yet, important barriers prevent access to psychological interventions for COFP (e.g., lack of providers, financial resources). This study will assess the feasibility and acceptability of adapting a single two-hour telehealth-delivered group course, Empowered Relief (ER), which was created for heterogenous chronic pain condition, into a multidisciplinary COFP clinic. ER addresses many existing barriers to assessing psychological interventions for COFP as it is deliverable via telehealth, in a group format, within a single session. This study hypothesizes that ER will demonstrate adequate feasibility and acceptability among patients with COFP. Participants will be recruited over a 6-month period from patients evaluated for an initial appointment at the University of Kentucky Orofacial Pain Clinic (UKOPC). A randomized waitlist control design will be used to inform a future efficacy trial. Specifically, new patients seeking an initial appointment at the UKOPC will be introduced to the study, and if they consent, they will be randomly assigned to participate in the next available ER course (i.e., immediate group) or the ER course offered the subsequent month (i.e., waitlist control group). All participants will provide feasibility and acceptability data after receiving the intervention. Those assigned to immediate group will provide biopsychosocial functioning and outcome data at one, two, and four weeks following the pain course. Those assigned to the immediate control group will provide data one, two, and four weeks before the intervention for a comparison group. Data from this study will inform design decisions for a future efficacy trial.

Read the detailed description

Chronic orofacial pain (COFP) is comprised of various disorders in the temporomandibular region causing pain that lasts more than three months and are associated with substantial physical and psychological burden. These disorders often co-occur with other conditions such as headache, general chronic pain, and psychiatric disorders. The etiology of COFP is complex, with environmental, psychosocial, emotional, and genetic factors contributing to the development, chronicity, and maintenance of these disorders. Regardless of etiology, COFPs are impactful, commonly resulting in interference with daily activities, reduced quality of life (QoL), and mental health difficulties. COFP disorders are therefore best treated with multidisciplinary approaches combining psychological interventions and comprehensive orofacial pain care.

Numerous psychological interventions for chronic pain are available, drawing from numerous theoretical orientations. Cognitive behavioral therapy (CBT) is a goal focused intervention designed to teach patients skills in restructuring cognitive distortions and thought patterns while promoting self-efficacy, which have shown to reduce pain intensity and psychological distress. Many relaxation techniques use a self-management approach by encouraging patients' role in managing their condition by learning skills to implement within their daily routine. Carlson (2008) categorizes multiple methods of relaxation techniques ranging from brief, easily taught skills to structured therapist-led interventions. He categorizes multiple methods of relaxation techniques ranging from brief, easily taught skills (brief relaxation techniques) to structured therapist-led interventions such as Physical Self-Regulation, where a therapist trains the patient through breathing exercises, clenching awareness, postural relaxation, and postural reeducation (progressive relaxation training).

Despite the multitude of empirically-supported psychological interventions available, they all share common obstacles; namely, that uptake of these interventions in COFP clinic is low due to lack of sufficient specialized orofacial pain treatment providers, financial resources, and mental health stigma, and patients not expecting to have clinical psychologists involved in their COFP management, which has historically been treated (with minimal success) by dental providers alone, among other obstacles. Additionally, while literature suggests the effectiveness of these interventions for COFP populations, patients are often met with access related issues. These treatments introduce barriers through financial costs associated with healthcare and travel, lack of geographic access, especially for patients in rural communities, and few professionally certified clinicians to provide services. Consequently, there is also a lack of multimodal tertiary clinics available that offer treatments combining dental, psychological, and behavioral healthcare, leading patients to travel far distances for interdisciplinary treatments that can last hours across multiple sessions. Geographic access also poses a significant issue because interdisciplinary COFP clinics are scarce, with many states not having any access to specialty care, despite their being empirical evidence for greater longitudinal outcomes in COFP patients.

Recent literature has identified Empowered Relief (ER), a virtual single-session, two-hour group-based intervention developed at Stanford University that overcomes many of the existing obstacles. ER introduces evidenced-based skills through a single session, two-hour course where patients develop tools that allow them to become self-sufficient in managing their chronic pain. The session can be held through a virtual format, providing accessible care and reducing patient travel or long stays. The training also provides space for multiple patients to receive care at one time as ER is hosted in a group format, allowing more patients to receive treatment over time.

The effectiveness of ER was first demonstrated through a pilot study that included participants with various chronic pain conditions which indicated significant reduction in distress and improved participants' ability to use self-regulation strategies for pain management 4 weeks post intervention. Additionally, a randomized control study found that one session of ER was just as effective as eight weeks of traditional CBT for reducing pain catastrophizing and pain intensity in individuals with chronic lower back pain. Currently, no literature to date has investigated the feasibility and acceptability of ER in patients with COFP, indicating a gap in literature. The present study aims to fill this gap to work towards the identification of a low-cost and low-burden intervention for this underserved population.

02

Conditions studied

  • Chronic Orofacial Pain
  • Orofacial Pain

Browse trials for

Keywords

  • Orofacial Pain
  • Empowered Relief
  • Psychological Intervention
03

In context

Facial Pain

182 studies on the registry are indexed under Facial Pain; 61 are open to participants now.

This study's planned enrollment of 200 is above the median of 50 across 132 interventional studies indexed under Facial Pain.

Browse Facial Pain studies →

Lead sponsor

University of Kentucky is the lead sponsor of 68 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 5, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must be in the state of Kentucky
  • Must be 18 years or older
  • Ability to read, write, and speak English
  • Experienced pain longer than 3 months
  • Treatment-seeking patient at University of Kentucky Orofacial Pain Clinic
  • Must have the appropriate technology to access telehealth (e.g., laptop, stable connection)

Exclusion criteria

Exclusion Criteria:

  • Suicidal ideation with intent in the last two weeks
  • Homicidal ideation with intent in the last 2 weeks
  • Mania symptoms in the past 6 months
  • Hypomania symptoms in the past 6 months
  • Psychosis symptoms in the past 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Immediate Intervention

    Participants in this arm will be scheduled to partake in the next available Empowered Relief course

    Behavioral: Empowered Relief

  • No intervention
    Waitlist Control

    Participants in this arm will be scheduled to partake in the Empowered Relief course approximately 1 month after they consent for the study

Interventions

  • BehavioralEmpowered Relief

    Empowered Relief (ER) is a single-session, 2-hour pain management course designed with the purpose of assisting individuals with chronic pain to gain skills for self-pain management. ER is taught through a PowerPoint presentation which includes pain education, self-regulatory skills (i.e., relaxation, cognitive reframing, and self-soothing), and mindfulness skills, all grounded in pain-CBT theory (Darnall et al., 2021). The intervention will be delivered by a certified Empowered Relief instructor.

06

What researchers measure

Primary outcomes

  1. Recruitment Rate

    The number of patients who are consented into the study from the UK Orofacial Pain Clinic per month

    Time frame: Baseline (week 0)

  2. Retention Rate

    The number of patients who were consented into the study and completed the one month follow-up outcome survey

    Time frame: Follow up outcome survey at one month (approximately)

  3. Client Satisfaction

    Client Satisfaction Questionnaire (CSQ) 8 items on a 4 point likert scale. Higher scores on items 1, 3, 6, 7, likert scale equate to greater satisfaction. Higher scores on items 2, 4, 5, and 8 likert scale equate to lower satisfaction.

    Time frame: Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.

  4. Empowered Relief Post Course Survey

    Empowered Relief Post-Course Survey 5 items on a 6 point Likert scale. Higher scores equate to greater satisfaction with Empowered Relief course, content, and practice.

    Time frame: Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.

  5. Satisfaction with Class

    Satisfaction with Class (Empowered Relief) is a 11 item survey. Items 1 - 5 are on a 0 to 10 numeric scale with higher scores equating to greater satisfaction. Items 6 - 10 are on a 7 point Likert scale with higher scores equating to greater satisfaction. Item 11 is a closed-ended single select question which includes three answer options.

    Time frame: Immediate Intervention - approximately one week after consent and directly after pain management intervention attendance. Waitlist Control - approximately one month after consent and directly after pain management intervention attendance.

Secondary outcomes

  1. PTSD Symptoms

    The PTSD Symptom Checklist (Past Month) (PCL-5) will assess if the participant has experienced a traumatic event as defined by the DSM-5-TR and if they have experienced PTSD symptoms in the past month related to the event. The PCL-5 is a 20 item questionnaire with each item rated on a 5-point likert scale ranging from 0 - 4. Higher scores equate to greater intensity and interference of PTSD symptoms.

    Time frame: Baseline (Week 0)

  2. Headache Impact

    The Headache Impact Test (HIT-6) 6 item questionnaire evaluates pain intensity, life interference, and psychological distress due to headaches. Items are rated on a 5 point likert scale. Higher scores equate greater headache impact.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow up (Week 4)

  3. PTSD Symptoms (Past Two Weeks)

    The PTSD Short Form (PCL-5-SF) are administered to participants who indicate having experienced a trauma. The PCL-5-SF is a 4 item questionnaire on a 5 point likert scale. Higher scores equate to greater PTSD symptoms.

    Time frame: Two Week Follow up (Week 2), One Month Follow up (Week 4)

  4. Pain Self Efficacy

    The Pain Self-Efficacy Questionnaire (PSEQ-2) includes two items with a 6 point likert scale. Lower scores equate to less pain self-efficacy.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)

  5. Pain Catastrophizing

    The University of Washington Concerns About Pain Scale (UW-CAP-6) evaluates participants pain catastrophizing and negative thoughts in regard to their chronic pain. UW-CAP-6 short form includes 6 items rated on a 5 point likert scale with higher scores equating to greater levels of pain catastrophizing.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)

  6. Acceptance of Chronic Pain

    The Chronic Pain Acceptance Questionnaire (CPAQ-8) is an 8 item questionnaire that evaluates participants acceptance of their chronic pain condition. Items are rated on a 7 point likert scale with higher scores equating to greater pain acceptance.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow Up (Week 4)

  7. Pain Interference

    The PROMIS Pain Interference Short Form (PROMIS 4a) evaluates how much pain interferes with their daily life. The PROMIS 4a includes 4 items rated on a 5 point likert scale with higher scores equating to pain having greater interference on their life.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)

  8. Anxiety and Depression

    The Patient Health Questionnaire (PHQ-4) is a brief questionnaire evaluating the participants anxiety and depression with 4 items rated on a 4 point likert scale with higher scores equating to greater levels of distress.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)

  9. Fatigue

    The PROMIS-FAT-4 is a brief questionnaire that evaluates participants level and impact of fatigue with 4 items on a 5 point likert scale with higher scores equating to greater severity of fatigue.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)

  10. Satisfaction with Life

    The Satisfaction with Life Scale (SWLS) evaluates participants judgement of satisfaction with the conditions of their life with 5 items rated on a 7 point likert scale with higher scores equating to greater satisfaction with their life's conditions.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)

  11. Jaw Function

    The Jaw Functional Limitation Scale (JFLS) short form evaluates participants jaw function limitations with 8 items on an 11 point numeric scale with higher scores equating to greater jaw function limitation.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)

  12. Insomnia Severity

    The Insomnia Severity Index (ISI-brief) evaluates the participants experience with sleep and the the severity and impact of insomnia if present. The brief ISI measure includes 7 items on a 5 point likert scale with higher scores equating to greater impact and severity of insomnia symptoms.

    Time frame: Baseline (Week 0), Two Week Follow Up (Week 2), One Month Follow-Up (Week 4)

07

Study locations

1 site
08

References and documents

Publications

  • Priyank H, Shankar Prasad R, Shivakumar S, Sayed Abdul N, Pathak A, Cervino G, Cicciu M, Minervini G. Management protocols of chronic Orofacial Pain: A Systematic Review. Saudi Dent J. 2023 Jul;35(5):395-402. doi: 10.1016/j.sdentj.2023.04.003. Epub 2023 May 13. PubMed 37520608 ↗
  • Lagisetty P, Slat S, Thomas J, Macleod C, Golmirzaie G, Bohnert AS. Access to Multimodal Pain Management for Patients with Chronic Pain: an Audit Study. J Gen Intern Med. 2021 Mar;36(3):818-820. doi: 10.1007/s11606-020-05866-3. Epub 2020 May 6. No abstract available. PubMed 32378013 ↗
  • Darnall BD, Sturgeon JA, Kao MC, Hah JM, Mackey SC. From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing. J Pain Res. 2014 Apr 25;7:219-26. doi: 10.2147/JPR.S62329. eCollection 2014. PubMed 24851056 ↗
  • Davin SA, Abshire L, Thompson N, Savage J, Amps J, Pelle D, Steinmetz M. Acceptability of a brief behavioral pain treatment to enhance recovery after surgery. N Am Spine Soc J. 2026 Mar 27;26:100880. doi: 10.1016/j.xnsj.2026.100880. eCollection 2026 Jun. PubMed 42063569 ↗
  • Litt MD, Tennen H. What are the most effective coping strategies for managing chronic pain? Pain Manag. 2015;5(6):403-6. doi: 10.2217/pmt.15.45. Epub 2015 Sep 24. No abstract available. PubMed 26399377 ↗
  • Avinash B, Shivamallu AB, Ashwini TS, Sowmya HK, Ali I, Kudagi VS. Interprofessional Management of Orofacial Pain: Wearing Many Hats! J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S65-S67. doi: 10.4103/jpbs.JPBS_556_21. Epub 2022 Jul 13. PubMed 36110700 ↗
  • Ziadni MS, Anderson SR, Gonzalez-Castro L, Darnall BD. Comparative efficacy of a single-session "Empowered Relief" videoconference-delivered group intervention for chronic pain: study protocol for a randomized controlled trial. Trials. 2021 May 22;22(1):358. doi: 10.1186/s13063-021-05303-8. PubMed 34022930 ↗
  • Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6) across episodic and chronic migraine. Cephalalgia. 2011 Feb;31(3):357-67. doi: 10.1177/0333102410379890. Epub 2010 Sep 6. PubMed 20819842 ↗
  • Weathers, F.W., Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., & Schnurr, P.P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov.
  • Tan, Gabriel & Glaros, Alan & Sherman, Richard & Wong, Chin. (2017). Integrative Approaches to Orofacial Pain: Role of Biofeedback and Hypnosis. 10.1007/978-3-319-51508-3_27.
  • Schrepf A, Maixner W, Fillingim R, Veasley C, Ohrbach R, Smith S, Williams DA. The Chronic Overlapping Pain Condition Screener. J Pain. 2024 Jan;25(1):265-272. doi: 10.1016/j.jpain.2023.08.009. Epub 2023 Aug 24. PubMed 37633574 ↗
  • Stone S, Wainwright E, Guest A, Ghiglieri C, Zeyen A, Gooberman-Hill R. Social influences in the experience of transition to or from long-term (chronic) pain: A systematic review of qualitative research studies. PLoS One. 2025 Jul 10;20(7):e0327984. doi: 10.1371/journal.pone.0327984. eCollection 2025. PubMed 40638632 ↗
  • Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151. PubMed 24482784 ↗
  • Sangalli L, Fernandez-Vial D, Moreno-Hay I, Boggero I. Telehealth Increases Access to Brief Behavioral Interventions in an Orofacial Pain Clinic During the COVID-19 Pandemic: A Retrospective Study. Pain Med. 2022 Apr 8;23(4):799-806. doi: 10.1093/pm/pnab295. PubMed 34623433 ↗
  • Perez L, Palenski P, Monson EA, Contreras L, Dorsonne B, Hailu AY, Gedeon K, Boyd H, Ziadni M, Herrick A, Friedman A, Xu J, Hong J, Tian L, Darnall BD. Online 1-session Empowered Relief in Marfan syndrome and related diseases: a single-arm feasibility and pilot efficacy study. Sci Rep. 2026 Jan 6;16(1):499. doi: 10.1038/s41598-025-29943-x. PubMed 41495090 ↗
  • Ohrbach R, Larsson P, List T. The jaw functional limitation scale: development, reliability, and validity of 8-item and 20-item versions. J Orofac Pain. 2008 Summer;22(3):219-30. PubMed 18780535 ↗
  • Adair Monson E, Mardian A, Saxena K, Dorsonne B, Hailu AY, Heggan E, Riazi G, Slater K, Poupore-King H, Clifton J, Perez L, Tian L, Porter J, Denton S, Hanson ER, Miefert J, Thorn BE, Mackey SC, Cheung M, Darnall BD. Randomized comparative effectiveness study of 1-session vs 8-session online behavioral treatment for chronic pain: protocol for the national PROGRESS study. Pain Med. 2026 Jul 1;27(7):839-850. doi: 10.1093/pm/pnag027. PubMed 41712512 ↗
  • Miller ME, Bowling WR, Borders TF, Kim N, Boggero IA. Patient-reported feasibility, acceptability, and satisfaction of psychological telehealth orofacial pain interventions: a mixed-methods study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2026 Mar;141(3):334-342. doi: 10.1016/j.oooo.2025.10.009. Epub 2025 Oct 24. PubMed 41318276 ↗
  • McIntyre RS, Patel MD, Masand PS, Harrington A, Gillard P, McElroy SL, Sullivan K, Montano CB, Brown TM, Nelson L, Jain R. The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder. Curr Med Res Opin. 2021 Jan;37(1):135-144. doi: 10.1080/03007995.2020.1860358. Epub 2021 Jan 6. PubMed 33300813 ↗
  • Lovette BC, Bannon SM, Spyropoulos DC, Vranceanu AM, Greenberg J. "I Still Suffer Every Second of Every Day": A Qualitative Analysis of the Challenges of Living with Chronic Orofacial Pain. J Pain Res. 2022 Jul 29;15:2139-2148. doi: 10.2147/JPR.S372469. eCollection 2022. PubMed 35935679 ↗
  • Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available. PubMed 10245370 ↗
  • Labanca M, Giano M, Franco C, Rezzani R. Orofacial Pain and Dentistry Management: Guidelines for a More Comprehensive Evidence-Based Approach. Diagnostics (Basel). 2023 Sep 4;13(17):2854. doi: 10.3390/diagnostics13172854. PubMed 37685392 ↗
  • Goldthorpe J, Lovell K, Peters S, McGowan L, Nemeth I, Roberts C, Aggarwal VR. A Pilot Randomized Controlled Trial of a Guided Self-Help Intervention to Manage Chronic Orofacial Pain. J Oral Facial Pain Headache. 2017 Winter;31(1):61-71. doi: 10.11607/ofph.1665. PubMed 28118422 ↗
  • In J. Introduction of a pilot study. Korean J Anesthesiol. 2017 Dec;70(6):601-605. doi: 10.4097/kjae.2017.70.6.601. Epub 2017 Nov 14. PubMed 29225742 ↗
  • Fjorback LO, Arendt M, Ornbol E, Fink P, Walach H. Mindfulness-based stress reduction and mindfulness-based cognitive therapy: a systematic review of randomized controlled trials. Acta Psychiatr Scand. 2011 Aug;124(2):102-19. doi: 10.1111/j.1600-0447.2011.01704.x. Epub 2011 Apr 28. PubMed 21534932 ↗
  • Esposito R, Sangalli L, Boggero IA, Kapos FP. Geographic and rural health care resource gaps in orofacial pain provider distribution across the United States. J Am Dent Assoc. 2026 Mar;157(3):294-304. doi: 10.1016/j.adaj.2025.12.021. Epub 2026 Feb 6. PubMed 41653175 ↗
  • de Oliveira Melchior M, Magri LV, Diaz-Serrano KV, Junior EBC, Fregni F, Pacheco-Barrios K, Lacchini R, Leite-Panissi CRA, Gherardi-Donato ECS. Impact of a Mindfulness-Based Intervention on Pain and Psychological Factors in Women With Chronic Painful Temporomandibular Disorders. J Oral Rehabil. 2025 Dec;52(12):2269-2281. doi: 10.1111/joor.70028. Epub 2025 Aug 6. PubMed 40767135 ↗
  • Darnall BD, Roy A, Chen AL, Ziadni MS, Keane RT, You DS, Slater K, Poupore-King H, Mackey I, Kao MC, Cook KF, Lorig K, Zhang D, Hong J, Tian L, Mackey SC. Comparison of a Single-Session Pain Management Skills Intervention With a Single-Session Health Education Intervention and 8 Sessions of Cognitive Behavioral Therapy in Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Netw Open. 2021 Aug 2;4(8):e2113401. doi: 10.1001/jamanetworkopen.2021.13401. PubMed 34398206 ↗
  • Darnall BD, Ziadni MS, Krishnamurthy P, Flood P, Heathcote LC, Mackey IG, Taub CJ, Wheeler A. "My Surgical Success": Effect of a Digital Behavioral Pain Medicine Intervention on Time to Opioid Cessation After Breast Cancer Surgery-A Pilot Randomized Controlled Clinical Trial. Pain Med. 2019 Nov 1;20(11):2228-2237. doi: 10.1093/pm/pnz094. PubMed 31087093 ↗
  • Carriere JS, Coutu MF, Darnall BD, Leonard G, Royer MP, Li MY, Bordeleau M, Durand MJ. Changes in Pain Catastrophizing and Related Outcomes Following a Single-Session Empowered Relief Intervention Delivered by Physical Therapists in Workers with Low Back Pain: A Pilot Study. J Pain Res. 2025 Sep 17;18:4845-4857. doi: 10.2147/JPR.S527830. eCollection 2025. PubMed 41000505 ↗
  • Carlson CR. Psychological considerations for chronic orofacial pain. Oral Maxillofac Surg Clin North Am. 2008 May;20(2):185-95, vi. doi: 10.1016/j.coms.2007.12.002. PubMed 18343324 ↗
  • Calkins ME, Ered A, Moore TM, White LK, Taylor J, Moxam AB, Ruparel K, Wolf DH, Satterthwaite TD, Kohler CG, Gur RC, Gur RE. Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth. Schizophr Bull. 2025 Sep 8;51(5):1242-1253. doi: 10.1093/schbul/sbae224. PubMed 39792431 ↗
  • Bertoni M, Telias I, Urner M, Long M, Del Sorbo L, Fan E, Sinderby C, Beck J, Liu L, Qiu H, Wong J, Slutsky AS, Ferguson ND, Brochard LJ, Goligher EC. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care. 2019 Nov 6;23(1):346. doi: 10.1186/s13054-019-2617-0. PubMed 31694692 ↗
  • Aggarwal VR, Fu Y, Main CJ, Wu J. The effectiveness of self-management interventions in adults with chronic orofacial pain: A systematic review, meta-analysis and meta-regression. Eur J Pain. 2019 May;23(5):849-865. doi: 10.1002/ejp.1358. Epub 2019 Feb 7. PubMed 30620145 ↗
  • Abrahamsen R, Zachariae R, Svensson P. Effect of hypnosis on oral function and psychological factors in temporomandibular disorders patients. J Oral Rehabil. 2009 Aug;36(8):556-70. doi: 10.1111/j.1365-2842.2009.01974.x. PubMed 19604319 ↗
  • Fish RA, McGuire B, Hogan M, Morrison TG, Stewart I. Validation of the chronic pain acceptance questionnaire (CPAQ) in an Internet sample and development and preliminary validation of the CPAQ-8. Pain. 2010 Jun;149(3):435-443. doi: 10.1016/j.pain.2009.12.016. Epub 2010 Feb 25. PubMed 20188472 ↗
  • Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x. PubMed 10259963 ↗
  • Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601. PubMed 21532953 ↗
  • Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13. PubMed 16367493 ↗
  • Bingham Iii CO, Gutierrez AK, Butanis A, Bykerk VP, Curtis JR, Leong A, Lyddiatt A, Nowell WB, Orbai AM, Bartlett SJ. PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. J Patient Rep Outcomes. 2019 Feb 21;3(1):14. doi: 10.1186/s41687-019-0105-6. PubMed 30790155 ↗
  • Caro-Fuentes S, Sanabria-Mazo JP. A Systematic Review of the Psychometric Properties of the Patient Health Questionnaire-4 in Clinical and Nonclinical Populations. J Acad Consult Liaison Psychiatry. 2024 Mar-Apr;65(2):178-194. doi: 10.1016/j.jaclp.2023.11.685. Epub 2023 Nov 25. PubMed 38012988 ↗
  • Stephan A, Stadelmann VA, Leunig M, Impellizzeri FM. Measurement properties of PROMIS short forms for pain and function in total hip arthroplasty patients. J Patient Rep Outcomes. 2021 May 30;5(1):41. doi: 10.1186/s41687-021-00313-1. PubMed 34056667 ↗
  • Amtmann D, Bamer AM, Liljenquist KS, Cowan P, Salem R, Turk DC, Jensen MP. The Concerns About Pain (CAP) Scale: A Patient-Reported Outcome Measure of Pain Catastrophizing. J Pain. 2020 Nov-Dec;21(11-12):1198-1211. doi: 10.1016/j.jpain.2020.03.004. Epub 2020 Jun 13. PubMed 32544603 ↗
  • Nicholas MK, McGuire BE, Asghari A. A 2-item short form of the Pain Self-efficacy Questionnaire: development and psychometric evaluation of PSEQ-2. J Pain. 2015 Feb;16(2):153-63. doi: 10.1016/j.jpain.2014.11.002. Epub 2014 Nov 14. PubMed 25463701 ↗
  • Houts CR, McGinley JS, Wirth RJ, Cady R, Lipton RB. Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study. Qual Life Res. 2021 Mar;30(3):931-943. doi: 10.1007/s11136-020-02668-2. Epub 2020 Oct 20. PubMed 33079313 ↗
  • Zuromski KL, Ustun B, Hwang I, Keane TM, Marx BP, Stein MB, Ursano RJ, Kessler RC. Developing an optimal short-form of the PTSD Checklist for DSM-5 (PCL-5). Depress Anxiety. 2019 Sep;36(9):790-800. doi: 10.1002/da.22942. Epub 2019 Jul 29. PubMed 31356709 ↗
  • Forkus SR, Raudales AM, Rafiuddin HS, Weiss NH, Messman BA, Contractor AA. The Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5: A Systematic Review of Existing Psychometric Evidence. Clin Psychol (New York). 2023 Mar;30(1):110-121. doi: 10.1037/cps0000111. Epub 2022 Sep 8. PubMed 37378352 ↗
  • Cerimele JM, Russo J, Bauer AM, Hawrilenko M, Pyne JM, Dalack GW, Kroenke K, Unutzer J, Fortney JC. The Patient Mania Questionnaire (PMQ-9): a Brief Scale for Assessing and Monitoring Manic Symptoms. J Gen Intern Med. 2022 May;37(7):1680-1687. doi: 10.1007/s11606-021-06947-7. Epub 2021 Jun 18. PubMed 34145517 ↗
  • Horowitz LM, Snyder DJ, Boudreaux ED, He JP, Harrington CJ, Cai J, Claassen CA, Salhany JE, Dao T, Chaves JF, Jobes DA, Merikangas KR, Bridge JA, Pao M. Validation of the Ask Suicide-Screening Questions for Adult Medical Inpatients: A Brief Tool for All Ages. Psychosomatics. 2020 Nov-Dec;61(6):713-722. doi: 10.1016/j.psym.2020.04.008. Epub 2020 Apr 28. PubMed 32487323 ↗

Individual participant data

Plan to share: No — Participant health data will be protected.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.

Of 53 non-industry interventional studies with no phase under Facial Pain, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 12 months is below that.

Counting every sponsor, half of 57 studies reached it within 17 months; a quarter within 8 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2026
First posted
Sep 3, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Oct 1, 2027
CompletionEst.
Oct 1, 2028
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
6 inclusion criteria added, 1 removed; 5 exclusion criteria added, 1 removed
What changed in the criteria
Inclusion criteria
  • RemovedMust be 18 years or older; have the ability to read, write, and speak English; have experienced pain longer than 3 months; be a treatment-seeking patient at the University of Kentucky Orofacial Pain Clinic (UKOPC), and have the technological ability to participate in telehealth treatment in Kentucky (e.g., technology, connection, earbuds or headphones, private space in Kentucky).
  • AddedMust be in the state of Kentucky
  • AddedMust be 18 years or older
  • AddedAbility to read, write, and speak English
  • AddedExperienced pain longer than 3 months
  • AddedTreatment-seeking patient at University of Kentucky Orofacial Pain Clinic
  • AddedMust have the appropriate technology to access telehealth (e.g., laptop, stable connection)
Exclusion criteria
  • RemovedBecause the UKOPC is a training clinic, participants will be excluded if they report current or recent suicidal or homicidal ideation or intent in the last 2 weeks and/or symptoms of mania, hypomania, or psychosis in the past 6 months.
  • AddedSuicidal ideation with intent in the last two weeks
  • AddedHomicidal ideation with intent in the last 2 weeks
  • AddedMania symptoms in the past 6 months
  • AddedHypomania symptoms in the past 6 months
  • AddedPsychosis symptoms in the past 6 months
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Eligibility 6 inclusion criteria added, 1 removed; 5 exclusion criteria added, 1 removed
    What changed in the criteria
    Inclusion criteria
    • RemovedMust be 18 years or older; have the ability to read, write, and speak English; have experienced pain longer than 3 months; be a treatment-seeking patient at the University of Kentucky Orofacial Pain Clinic (UKOPC), and have the technological ability to participate in telehealth treatment in Kentucky (e.g., technology, connection, earbuds or headphones, private space in Kentucky).
    • AddedMust be in the state of Kentucky
    • AddedMust be 18 years or older
    • AddedAbility to read, write, and speak English
    • AddedExperienced pain longer than 3 months
    • AddedTreatment-seeking patient at University of Kentucky Orofacial Pain Clinic
    • AddedMust have the appropriate technology to access telehealth (e.g., laptop, stable connection)
    Exclusion criteria
    • RemovedBecause the UKOPC is a training clinic, participants will be excluded if they report current or recent suicidal or homicidal ideation or intent in the last 2 weeks and/or symptoms of mania, hypomania, or psychosis in the past 6 months.
    • AddedSuicidal ideation with intent in the last two weeks
    • AddedHomicidal ideation with intent in the last 2 weeks
    • AddedMania symptoms in the past 6 months
    • AddedHypomania symptoms in the past 6 months
    • AddedPsychosis symptoms in the past 6 months
    + 5 other changes: identifiers, verification date, description, conditions and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07802067
Lead sponsor
University of Kentucky
Responsible party
Ian Boggero, PhD (Associate Professor, University of Kentucky) — Principal investigator
First posted
Sep 3, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Oct 1, 2027 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Oct 5, 2026

Study contacts

Kathleen E Wakeman, M.S.
Contact
kewa246@uky.edu
508-759-8037
Kathleen E Wakeman, M.S.
principal investigator · University of Kentucky
Ian Boggero, PhD
study chair · University of Kentucky

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion